Page last updated: 2024-12-08

11-hydroxyyohimbine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 11-Hydroxyyohimbine: A Potent and Selective α2-Adrenergic Receptor Antagonist

11-hydroxyyohimbine (11-OHY) is a **potent and selective α2-adrenergic receptor antagonist**, meaning it blocks the action of the neurotransmitter norepinephrine at these receptors. This is crucial for research because α2-adrenergic receptors are involved in various physiological processes, making 11-OHY a valuable tool for studying:

**1. Neurotransmission and the Nervous System:**

* **Anxiety and Depression:** 11-OHY can modulate the release of norepinephrine and other neurotransmitters, which are implicated in anxiety and depression. This makes it a potential research tool for understanding and potentially treating these disorders.
* **Pain Perception:** 11-OHY can alter pain perception by affecting the release of pain-modulating neurotransmitters. It could be used to study the mechanisms of pain and potential new pain relief therapies.
* **Cognitive Function:** 11-OHY can influence cognitive function by altering the activity of the prefrontal cortex, which is involved in higher-level cognitive processes. This could be valuable for research into memory, attention, and decision-making.

**2. Cardiovascular System:**

* **Blood Pressure Regulation:** α2-adrenergic receptors play a role in regulating blood pressure, and 11-OHY can potentially influence blood pressure by blocking these receptors. This makes it a potential research tool for studying hypertension and other cardiovascular diseases.
* **Cardiac Function:** 11-OHY could be used to study the effects of α2-adrenergic receptor blockade on heart function and potential implications for heart disease.

**3. Other Systems:**

* **Metabolic Regulation:** 11-OHY might have implications for metabolic regulation by affecting the release of insulin and glucose. This could be relevant for research into diabetes and obesity.
* **Reproductive System:** 11-OHY could influence sexual function by affecting the activity of the sympathetic nervous system, which is involved in sexual arousal and orgasm. This could be relevant for research into sexual dysfunction.

**Importance for Research:**

11-OHY is a valuable research tool because of its:

* **High selectivity:** It primarily targets α2-adrenergic receptors, allowing researchers to specifically investigate the role of these receptors in different processes.
* **Potency:** It effectively blocks the activity of α2-adrenergic receptors, leading to observable effects in research models.
* **Availability:** It is readily available for research purposes, enabling researchers to conduct experiments and gain insights into the role of α2-adrenergic receptors.

Overall, 11-hydroxyyohimbine is a potent and selective α2-adrenergic receptor antagonist that is highly valuable for research in various fields, including neurology, cardiology, and endocrinology. Its unique properties allow researchers to investigate the role of α2-adrenergic receptors in numerous physiological processes and contribute to our understanding of complex diseases and potential treatment options.

11-hydroxyyohimbine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID183814
SCHEMBL ID564634
MeSH IDM0216290

Synonyms (11)

Synonym
11-hydroxyyohimbine
140405-13-6
11-hydroxy-yohimbine
yohimban-16-carboxylic acid, 11,17-dihydroxy-, methyl ester, (16alpha,17alpha)-
unii-1t5drz63hs
1t5drz63hs ,
yohimban-16-carboxylic acid, 11,17-dihydroxy-, methyl ester, (16.alpha.,17.alpha.)-
SCHEMBL564634
DTXSID60161328
Q27252855
methyl (1s,15r,18s,19r,20s)-6,18-dihydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
") oral absolute bioavailability of YO was 22."( Biopharmaceutics and metabolism of yohimbine in humans.
Chevanne, F; Dollo, G; Le Corre, P; Le Verge, R, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]